Notice that he's only referring to afrezza sales while under Mannkind control -- Sanofi did an infinitely better job of selling afrezza, humuliating all of Mannkind's efforts.
Mannkind has yet to come close to Sanofi's best numbers despite everything Mannkind has done in the over two years since they took back control.